(Q27021822)

I. J. Sutton

2

1 reference

M. Ghadiri

3

1 reference

L. Masters

4

1 reference

R. Zivadinov

5

1 reference

M. H. Barnett

6

1 reference

language of work or name

1 reference

August 2014

1 reference

American Journal of Neuroradiology

published in

1 reference

volume

35

1 reference

issue

8

1 reference

page(s)

1458-66

1 reference

The clinical course of neuromyelitis optica (Devic's syndrome).

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

MR imaging of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Brain magnetic resonance imaging abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Neuromyelitis optica with hypothalamic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Conventional brain MRI in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Neuromyelitis optica: not a multiple sclerosis variant

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Neuromyelitis optica in Brazil: a study on clinical and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Acute reversible periependymal ventricular enhancement in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

No MRI evidence of cortical lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Altered topological organization of white matter structural networks in patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Diffuse white matter damage is absent in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Inflammatory cortical demyelination in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Cortical pathology and cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Absence of cortical demyelination in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Postmortem verification of MS cortical lesion detection with 3D DIR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

White matter volume is decreased in the brain of patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Preferential spinal central gray matter involvement in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3592

21 January 2018

Identifiers

DOI

10.3174/AJNR.A3592

1 reference

Consolidated OpenCitations Corpus – April 2017

1425822

1425822

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference